AbbVie Stock (ABBV)

Yesterday as you are aware, AbbVie Stock (ABBV) fell on news that the company planned to buy out Allergen for $63 billion of cash and stock. Allergan’s shares popped 26% while AbbVie shares fell 15%.

I entered some repairs yesterday. Here are a few more repairs done today as I continue to generate profits despite the collapse of AbbVie Stock (ABBV).

 More On AbbVie Stock (ABBV) Trades and Repairs – Jun 26 2019





 

  Review All Quick Comments In Chronological Descending Order


Disclaimer: There are risks involved in all investment strategies and investors can and do lose capital. Trade at your own risk.

Internal Stock and Option Trades Links

Portfolio Listing by Years

My Principal Stocks Index

Trade Ideas for Members

Trade Alerts for Members

Put Selling Strategies

Put Selling Strategies For Members

Covered Calls Strategies

Covered Calls Strategies For Members

Profit And Income Strategies Index

Stock and Option Strategies For Members

Stock And Option Trades Explained For Members

Ask A Question About A Trade You Are In

Visit My Shop

Join The Free Options Forum